News in the Life Sciences Industry

GOTHENBURG, Sweden, July 15, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the outcome of an advisory board meeting held to discuss the current status and ongoing strategy for the development of arfolitixorin, the company's proprietary... Read more ››

RESEARCH TRIANGLE PARK, N.C., July 15, 2019 /PRNewswire/ -- Marken announced today that they have acquired HRTL based in Italy along with two additional companies in Austria and Hungary under the respective names of HETO and Der Kurier. Together the group operates with offices in Vienna, Milan,... Read more ››

STOCKHOLM, July 12, 2019 /PRNewswire/ -- During 14-17 July, RaySearch will exhibit its latest advances at the 61st AAPM Annual Meeting in San Antonio, US. The company will demonstrate RayCare® 3A*, the latest release of the groundbreaking oncology information system, and RayStation® 9A*,... Read more ››

STOCKHOLM, July 12, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) and C-RAD announced today that the companies have signed a sales and distribution agreement. C-RAD is a Swedish company specializing in positioning and surface scanning products. C-RAD offers surface image guided radiation therapy (SIGRT)... Read more ››

UPPSALA, Sweden, July 12, 2019 /PRNewswire/ -- Q-linea AB (publ) (Nasdaq Stockholm:QLINEA), a diagnostic company focused on developing and delivering solutions to accurately and rapidly diagnose infectious diseases, today announced MD Tiziana Di Martino has been appointed the company's Chief... Read more ››

STOCKHOLM, July 12, 2019 /PRNewswire/ -- Cyxone (publ.) a Swedish biotech in autoimmune diseases, today announced that the first healthy male volunteer has received the initial dose in its first-in-human, clinical phase I, trial with drug candidate T20K, in development for the treatment of... Read more ››

STOCKHOLM, July 11, 2019 /PRNewswire/ -- The James M. Slater, MD Proton Treatment and Research Center at Loma Linda University Medical Center, US, has chosen the treatment planning system (TPS) RayStation®* to replace its existing systems for photon and proton therapy planning, following... Read more ››

STOCKHOLM, July 11, 2019 /PRNewswire/ -- Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), to publish the company's Interim Report for the period January - June 2019 on Thursday, July 18, 2019 at 07:30 a.m. CET.

STOCKHOLM, July 11, 2019 /PRNewswire/ -- Significant events April-June

Improving all fundamentals